Dreyfus Andrew
SEC insider (Form 3/4/5 filer). CIK 0001670893. Director at Alto Neuroscience, Inc. (ANRO) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2026. Located in MOUNTAIN VIEW, CA.
Companies Dreyfus Andrew has filed insider reports for
- Alto Neuroscience, Inc. (ANRO): Director
- IRONWOOD PHARMACEUTICALS INC (IRWD): Director
Dreyfus Andrew
CIK: 0001670893
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
